Breaking News

TYK Medicines Inc (2410)

Hong Kong

Add to/Remove from a Portfolio Add to Watchlist

19.64 +0.54 +2.83%

08:59:59 - Closed. Currency in HKD

Type: Equity

Market: Hong Kong

ISIN: CNE100006L34

Volume: 4,469,500
Bid/Ask: 19.64 / 19.68
Day's Range: 18.66 - 20.15

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
Financials
Technical
Forum

TYK Medicines Inc Company Profile

Get an in-depth profile of TYK Medicines Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

153

Equity Type

ORD

TYK Medicines, Inc., a clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products. Its lead product candidate is TY-9591, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor for the treatment of brain metastases from non-small cell lung cancer (NSCLC) with EGFR mutations, and in locally advanced or metastatic NSCLC with EGFR L858R mutation. The company also develops TY-302, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor to treat solid tumors, including breast cancer and prostate cancer; TY-2136b, an oral ROS proto-oncogene 1/neurotrophic tyrosine receptor kinase inhibitor for the treatment of solid tumors; TY-2699a, a selective CDK7 inhibitor for the treatment of advanced/metastatic solid tumors; and TY-0540, a selective CDK2/4/6 inhibitor to treat advanced/metastatic solid tumors. In addition, it develops TY-4028, an oral exon 20 insertion-TKI targeting locally advanced or metastatic NSCLC with EGFR exon 20 or HER2 exon 20 insertions; TY-1091, a potent and selective rearranged during transfection proto-oncogene (RET) inhibitor for the treatment of advanced NSCLC with RET gene fusion, advanced medullary thyroid cancer with RET gene mutation, and other advanced solid tumors with RET gene alterations; TY-1054, an oral yes associated protein-transcriptional enhanced associate domain inhibitor for cancer treatment; TY-1210, a selective CDK2 inhibitor to treat solid tumors; TY-0609, a selective CDK4 inhibitor for the treatment of cancer; and TY-3200, an EGFR degrader. The company was incorporated in 2017 and is headquartered in Huzhou, China.

Contact Information

Address Tower A, Changxing World Trade Building Room 1403-2, Floor 14
No. 1278 Mingzhu Road Changxing Economic Development Zone Huzhou,
China

Phone 86 21 6167 6766

Fax -

Web www.tykmedicines.com

Top Executives

Name	Age	Since	Title
Eric Hong Gu	58	2017	Non-Executive Director
Wenqing Xu	59	2024	Independent Non- Executive Director
Xiaoying Meng	44	2021	Non-Executive Director
Jun Li	61	2021	Co-Founder & Non-Executive Director
Yusheng Wu	60	2017	Founder, Executive Chairman & CEO
Xiuhua Shen	52	2024	Independent Non- Executive Director
Chengshan Niu	43	2018	Chairperson of the Supervisory Board & Senior Dir. of Medicinal Chemistry Dept.
Yuting Leng	41	2024	Independent Non- Executive Director
Senquan Zhang	48	2024	Independent Non- Executive Director
Mingyu Jiang	37	2019	Non-Executive Director
Jing Shang	43	2021	Shareholder Representative Supervisor
Xiangyang Zhu	-	2025	Non-Executive Director
Apeng Liang	43	2017	Employee Representative Supervisor & Director of the Medicinal Chemistry Department

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

2410 Comments

Write your thoughts about TYK Medicines Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	4,865.55	+1.96	+0.04%
NSE All Share	132,499.55	+47.82	+0.04%
US 30	44,740.5	+238.3	+0.54%
US 500	6,335.7	+26.1	+0.41%
FTSE 100	9,077.88	+54.07	+0.60%
DAX	24,248.93	+221.76	+0.92%
South Africa Top 40	92,697.62	+1107.33	+1.21%

Brent Oil	68.23	-0.36	-0.52%
Crude Oil WTI	64.96	-0.35	-0.54%
Gold	3,444.47	+0.77	+0.02%
Silver	39.813	+0.258	+0.65%
Copper	5.8138	+0.0923	+1.61%
London Cocoa	5,351.00	+111.00	+2.12%
London Wheat	180.00	+1.00	+0.56%

Nigeria 10Y	16.083	0.000	0.00%
Nigeria 2Y	16.899	+0.000	+0.00%
U.K. 10Y	4.6130	+0.0410	+0.90%
Germany 10Y	2.6200	+0.0320	+1.24%
U.S. 10Y	4.374	+0.038	+0.88%
U.S. 5Y	3.910	+0.034	+0.88%
U.S. 2Y	3.853	+0.022	+0.57%

Fidelitybk	21.500	-0.200	-0.92%
Zenith Bank	70.75	0.00	0.00%
UBA	47.00	+0.30	+0.64%
First HoldCo	31.80	-0.20	-0.63%
Guaranty Trust Holding	93.90	+0.10	+0.11%
Sterling Bank	6.450	+0.230	+3.70%
Dangote Cement	489.00	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
2410	19.64	+0.54	+2.83%
SGOB	101.65	+2.93	+2.97%
Morgan Stanley Hu.	1.356	0.000	0.01%
Nikko GS World So.	5,233.000	+3.000	+0.06%
600763	43.15	+0.30	+0.70%
Bodenholm One	1,166.607	-57.750	-4.72%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.50	0.00%	17.61M
Guaranty Trust Holding	93.95	+0.16%	2.63M
Lafarge Africa	125.45	-0.44%	2.10M
UBA	47.00	+0.64%	1.93M
Aradel Holdings	508.00	+1.60%	1.61M
Zenith Bank	70.75	0.00%	1.25M
Dangote Sugar	58.50	+4.28%	1.09M

Name	Last	Chg. %	Vol.
Guinness Nigeria	106.45	+9.97%	2.27K
Ncr Nigeria	7.98	+9.92%	0.00K
Initiates	13.33	+9.89%	937.98K
Nem	21.950	+9.75%	574.21K
Nigerian Enamelware PLC	24.50	+9.62%	0.25K
Academy Press	7.67	+9.57%	26.35K
Chellarams	10.39	+9.02%	9.11K

Name	Last	Chg. %	Vol.
Union Dicon Salt	9.00	-10.00%	220.00K
Transcorp Power	288.00	-10.00%	36.53K
Geregu Power	1,027.40	-10.00%	1.03K
Conoil	211.10	-9.98%	3.47K
Redstarex	11.65	-9.83%	5.95K
Omatek Ventures	1.38	-4.17%	2.54M
Abctrans	5.06	-0.78%	119.87K